Federal contract award
75F40123F19095
TO OBTAIN A SCIENTIST II TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS? CELLULAR AND TISSUE THERAPY BRANCH (CTTB).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 75F40119D10015 |
| Set-aside | Not reported |
| Pricing type | LABOR HOURS |
| Obligations | $256.6K |
| Current contract value | $256.6K |
| Potential contract value / ceiling | $256.6K |
| Start date | Aug 11, 2023 |
| Current end date | Aug 31, 2025 |
| Potential end date | Aug 31, 2025 |
| Latest award activity | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00003 | $-101.4K | SCIENTIST II TO SUPPORT THE RESEARCH PROGRAM OF THE FDA/CBER, OFFICE OF THERAPEUTIC PRODUCTS CELLULAR AND TISSUE THERAPY BRANCH (CTTB). |
| Apr 1, 2025 | P00002 | $0 | EOI::DEFEND THE SPEND::EOI TERMINATION FOR CONVENIENCE AGREEMENT |
| May 29, 2024 | P00001 | $179.0K | TO OBTAIN A SCIENTIST II TO SUPPORT THE RESEARCH PROGRAM OF THE FDA'S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS CELLULAR AND TISSUE THERAPY BRANCH (CTTB). |
| Aug 11, 2023 | 0 | $179.0K | TO OBTAIN A SCIENTIST II TO SUPPORT THE RESEARCH PROGRAM OF THE FDA?S CENTER FOR BIOLOGICS EVALUATION AND RESEARCH, OFFICE OF THERAPEUTIC PRODUCTS? CELLULAR AND TISSUE THERAPY BRANCH (CTTB). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.